Tag Archives: IPOs

Tech IPOs could make a comeback in 2023, analyst says

Tech IPOs could make a comeback in 2023, analyst says

Though 2022 was a pretty IPO-less year, 2023 could signal a comeback in the tech IPO market, according to one analyst. “There are a lot of IPOs on the horizon that you’re going to see,” Ray Wang, founder and principal analyst at Constellation Research, told Yahoo Finance Live this week (video above). “I think people are waiting for the interest rates to stabilize. If the Fed can get to… [rate hikes of] 0.50% in December and 0.25% in January, I think we might have some hope.” Some tech… Source link

Read More »

How some of 2021’s biggest IPOs are faring

How some of 2021’s biggest IPOs are faring

A flurry of IPOs large and small have gone public during the pandemic, and some have been struggling more than others. Higher inflation and the likelihood of tighter monetary policy has beaten down the shares of many companies which went public last year, some of which have yet to report a profit. The biggest IPOs of 2021 and 2020, measured by the amount of money raised, shows shares of the top five initial public offerings of last year have fared worse than the largest ones to go public in… Source link

Read More »

The 5 most anticipated IPOs of 2022

The 5 most anticipated IPOs of 2022

Over the last year, the markets have contended with a global shipping crisis, the ongoing pandemic, and creeping inflation. Despite those risks, a huge number of companies made their public debuts in 2021. We’re talking Coinbase (COIN), Rent the Runway (RENT), Robinhood (HOOD), and, of course, electric vehicle makers Lucid (LCID) and Rivian (RVIN). Not every company that went public performed well, though. While some 399 initial public offerings raised $142.5 billion in 2021, the majority… Source link

Read More »

China Unveils Sweeping Rules for Foreign IPOs in Didi’s Wake

China Unveils Sweeping Rules for Foreign IPOs in Didi’s Wake

(Bloomberg) — China has unveiled sweeping regulations governing overseas share sales by the country’s firms, taking one of its biggest steps to tighten scrutiny on international debuts in the wake of Didi Global Inc.’s controversial listing. Most Read from Bloomberg The regulations, issued by the country’s securities watchdog, commerce ministry and top economic planning agency over the past week, cast more uncertainty over the prospects for overseas initial public offerings that had… Source link

Read More »

China Unveils Sweeping Rules for Foreign IPOs in Didi’s Wake – Yahoo Finance

China Unveils Sweeping Rules for Foreign IPOs in Didi’s Wake – Yahoo Finance

(Bloomberg) — China has unveiled sweeping regulations governing overseas share sales by the country’s firms, taking one of its biggest steps to tighten scrutiny on international debuts in the wake of Didi Global Inc.’s controversial listing. Most Read from Bloomberg The regulations, issued by the country’s securities watchdog, commerce ministry and top economic planning agency over the past week, cast more uncertainty over the prospects for overseas initial public offerings that had… Source link

Read More »

China to Close Loophole Used by Tech Firms for Foreign IPOs

China to Close Loophole Used by Tech Firms for Foreign IPOs

(Bloomberg) — China is planning to ban companies from going public on foreign stock markets through variable interest entities, according to people familiar with the matter, closing a loophole long used by the country’s technology industry to raise capital from overseas investors. Most Read from Bloomberg The ban, intended in part to address concerns over data security, is among changes included in a new draft of China’s overseas listing rules that may be finalized as soon as this month,… Source link

Read More »

Here are the most anticipated IPOs and new listings for Q4 2021 and early 2022

Here are the most anticipated IPOs and new listings for Q4 2021 and early 2022

It has been a record-breaking year for new public company listings — including IPOs, direct listings and SPACs — with total U.S. issuance standing at $257 billion. Though most unicorns that grew up over the last decade have found their way to the public markets, a few large holdouts remain in the pipeline for the coming quarters. A new wrinkle is popping up as well, which potentially threatens to introduce delays. Only a day after the latest consumer-facing unicorn, Warby Parker (WRBY),… Source link

Read More »

Alibaba’s sexual assault scandal and more delayed IPOs

Alibaba’s sexual assault scandal and more delayed IPOs

Hello and welcome back to TechCrunch’s China roundup, a digest of recent events shaping the Chinese tech landscape and what they mean to people in the rest of the world. A sexual assault case at Alibaba has sparked a new round of #MeToo reckoning in China. Industry observers believe this is a watershed moment for the fight against China’s allegedly misogynist tech industry. Meanwhile, social media operators are still undecided on how to deal with the unprecedented public uproar against the… Source link

Read More »

China Snags World’s Biggest IPOs While Hong Kong Listings Dry Up

China Snags World’s Biggest IPOs While Hong Kong Listings Dry Up

(Bloomberg) — Initial public offerings are coming thick and fast in mainland China, with Shanghai set to host the world’s two biggest listings this year as domestic investors look past the government’s regulatory crackdown. It’s a different story in Hong Kong, a global center for IPOs that’s seen only one offering so far this month. International investors who use the financial hub as a window into China are increasingly concerned by policy risks in sectors ranging from technology… Source link

Read More »

Big Pharma Earnings, Iterum FDA Decision, Alzheimer’s Conference, IPOs and More

Big Pharma Earnings, Iterum FDA Decision, Alzheimer’s Conference, IPOs and More

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season. Big pharma companies, including Johnson & Johnson (NYSE: JNJ) and Novartis AG (NYSE: NVS) reported forecast-beating results and issued positive guidance. Preannouncements from the space were also largely positive. Moderna, Inc.’s (NASDAQ: MRNA) buoyancy spilled over into the week. The … Source link

Read More »